Non‑compliances were observed involving “nodular clotting after administration of the product in several patients”, with no confirmed cause, which may directly lead to negative health consequences for patients. Potential effects: thrombosis, vascular complications, health risk.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use POLIPARIN medicinal product from batch E38310003A (expiry 31.08.2026); check the batch number before use; if the product has been administered, consider consulting a physician.
The Chief Pharmaceutical Inspector suspended the distribution of POLIPARIN 25000 IU/5 ml, batch E38310003A, throughout the country and granted the decision immediate enforceability; the company was ob...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related